Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. 1996 February 15; 97(4): 941–948.
PMCID: PMC507139

Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene.


Glycogen storage disease type IV (GSD-IV) is an autosomal recessive disease resulting from deficient glycogen-branching enzyme (GBE) activity. The classic and most common form is progressive liver cirrhosis and failure leading to either liver transplantation or death by 5 yr of age. However, the liver disease is not always progressive. In addition, a neuromuscular type of the disease has been reported. The molecular basis of GSD-IV is not known, nor is there a known reason for the clinical variability. We studied the GBE gene in patients with various presentations of GSD-IV. Three point mutations in the GBE gene were found in two patients with the classical presentation: R515C, F257L, and R524X. Transient expression experiments showed that these mutations inactivated GBE activity. Two point mutations, L224P and Y329S, were detected in two separate alleles of a patient with the nonprogressive hepatic form. The L224P resulted in complete loss of GBE activity, whereas the Y329S resulted in loss of approximately 50% of GBE activity. The Y329S allele was also detected in another patient with the nonprogressive form of GSD-IV but not in 35 unrelated controls or in patients with the more severe forms of GSD-IV. A 210-bp deletion from nucleotide 873 to 1082 of the GBE cDNA was detected in a patient with the fatal neonatal neuromuscular presentation. This deletion, representing the loss of one full exon, was caused by a 3' acceptor splicing site mutation (ag to aa). The deletion abolished GBE activity. Our studies indicate that the three different forms of GSD-IV were caused by mutations in the same GBE gene. The data also suggest that the significant retention of GBE activity in the Y329S allele may be a reason for the mild disease. Further study of genotype/phenotype correlations may yield useful information in predicting the clinical outcomes.

Full Text

The Full Text of this article is available as a PDF (364K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Servidei S, DiMauro S. Disorders of glycogen metabolism of muscle. Neurol Clin. 1989 Feb;7(1):159–178. [PubMed]
  • Brown BI, Brown DH. Lack of an alpha-1,4-glucan: alpha-1,4-glucan 6-glycosyl transferase in a case of type IV glycogenosis. Proc Natl Acad Sci U S A. 1966 Aug;56(2):725–729. [PubMed]
  • Guerra AS, van Diggelen OP, Carneiro F, Tsou RM, Simoes S, Santos NT. A juvenile variant of glycogenosis IV (Andersen disease). Eur J Pediatr. 1986 Aug;145(3):179–181. [PubMed]
  • Greene HL, Brown BI, McClenathan DT, Agostini RM, Jr, Taylor SR. A new variant of type IV glycogenosis: deficiency of branching enzyme activity without apparent progressive liver disease. Hepatology. 1988 Mar-Apr;8(2):302–306. [PubMed]
  • Brown BI, Brown DH. Branching enzyme activity of cultured amniocytes and chorionic villi: prenatal testing for type IV glycogen storage disease. Am J Hum Genet. 1989 Mar;44(3):378–381. [PubMed]
  • Tang TT, Segura AD, Chen YT, Ricci LM, Franciosi RA, Splaingard ML, Lubinsky MS. Neonatal hypotonia and cardiomyopathy secondary to type IV glycogenosis. Acta Neuropathol. 1994;87(5):531–536. [PubMed]
  • van Noort G, Straks W, Van Diggelen OP, Hennekam RC. A congenital variant of glycogenosis type IV. Pediatr Pathol. 1993 Sep-Oct;13(5):685–698. [PubMed]
  • Herrick MK, Twiss JL, Vladutiu GD, Glasscock GF, Horoupian DS. Concomitant branching enzyme and phosphorylase deficiencies. An unusual glycogenosis with extensive neuronal polyglucosan storage. J Neuropathol Exp Neurol. 1994 May;53(3):239–246. [PubMed]
  • Zellweger H, Mueller S, Ionasescu V, Schochet SS, McCormick WF. Glycogenosis. IV. A new cause of infantile hypotonia. J Pediatr. 1972 May;80(5):842–844. [PubMed]
  • Servidei S, Riepe RE, Langston C, Tani LY, Bricker JT, Crisp-Lindgren N, Travers H, Armstrong D, DiMauro S. Severe cardiopathy in branching enzyme deficiency. J Pediatr. 1987 Jul;111(1):51–56. [PubMed]
  • Reusche E, Aksu F, Goebel HH, Shin YS, Yokota T, Reichmann H. A mild juvenile variant of type IV glycogenosis. Brain Dev. 1992 Jan;14(1):36–43. [PubMed]
  • Schröder JM, May R, Shin YS, Sigmund M, Nase-Hüppmeier S. Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis). Acta Neuropathol. 1993;85(4):419–430. [PubMed]
  • Lossos A, Barash V, Soffer D, Argov Z, Gomori M, Ben-Nariah Z, Abramsky O, Steiner I. Hereditary branching enzyme dysfunction in adult polyglucosan body disease: a possible metabolic cause in two patients. Ann Neurol. 1991 Nov;30(5):655–662. [PubMed]
  • Bruno C, Servidei S, Shanske S, Karpati G, Carpenter S, McKee D, Barohn RJ, Hirano M, Rifai Z, DiMauro S. Glycogen branching enzyme deficiency in adult polyglucosan body disease. Ann Neurol. 1993 Jan;33(1):88–93. [PubMed]
  • Brown DH, Brown BI. Studies of the residual glycogen branching enzyme activity present in human skin fibroblasts from patients with type IV glycogen storage disease. Biochem Biophys Res Commun. 1983 Mar 16;111(2):636–643. [PubMed]
  • Thon VJ, Khalil M, Cannon JF. Isolation of human glycogen branching enzyme cDNAs by screening complementation in yeast. J Biol Chem. 1993 Apr 5;268(10):7509–7513. [PubMed]
  • Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. [PubMed]
  • Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. [PubMed]
  • Benton WD, Davis RW. Screening lambdagt recombinant clones by hybridization to single plaques in situ. Science. 1977 Apr 8;196(4286):180–182. [PubMed]
  • Iwahana H, Tsujisawa T, Katashima R, Yoshimoto K, Itakura M. PCR with end trimming and cassette ligation: a rapid method to clone exon-intron boundaries and a 5'-upstream sequence of genomic DNA based on a cDNA sequence. PCR Methods Appl. 1994 Aug;4(1):19–25. [PubMed]
  • Ding JH, Yang BZ, Bao Y, Roe CR, Chen YT. Identification of a new mutation in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. Am J Hum Genet. 1992 Jan;50(1):229–233. [PubMed]
  • Zimmerman CP, Gold AM. Isolation and characterization of glycogen branching enzyme from rabbit liver. Biochemistry. 1983 Jul 5;22(14):3387–3392. [PubMed]
  • Satoh K, Sato K. Purification of RNA associated and unassociated forms of 1,4-alpha-glucan branching enzyme from rat liver. J Biochem. 1982 Apr;91(4):1129–1137. [PubMed]
  • Thon VJ, Vigneron-Lesens C, Marianne-Pepin T, Montreuil J, Decq A, Rachez C, Ball SG, Cannon JF. Coordinate regulation of glycogen metabolism in the yeast Saccharomyces cerevisiae. Induction of glycogen branching enzyme. J Biol Chem. 1992 Jul 25;267(21):15224–15228. [PubMed]
  • Baba T, Kimura K, Mizuno K, Etoh H, Ishida Y, Shida O, Arai Y. Sequence conservation of the catalytic regions of amylolytic enzymes in maize branching enzyme-I. Biochem Biophys Res Commun. 1991 Nov 27;181(1):87–94. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation